(Q40356819)

English

Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice

scientific article published on 6 September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

lipopolysaccharide

0 references

attenuated vaccine

1 reference

based on heuristic

inferred from title

Francisella tularensis

object named as

Francisella tularensis

1 reference

based on heuristic

inferred from title

Richard W Titball

8

object named as

Richard W Titball

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Gill Hartley

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Rosa Taylor

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jo Prior

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sarah Newstead

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Paul G Hitchen

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Howard R Morris

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Anne Dell

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

6 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

989-996

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

The tularaemia vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Protection afforded by heat shock protein 60 from Francisella tularensis is due to copurified lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Structural analysis of Francisella tularensis lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Structural characterization of lipo-oligosaccharide (LOS) from Yersinia pestis: regulation of LOS structure by the PhoPQ system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Structure of the O-antigen of Francisella tularensis strain 15.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.075

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.08.075

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40356819&oldid=1896039351"